Example：10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
E2F5 Promotes the Malignancy of Ovarian Cancer Via the Regulation of Hippo and Wnt Pathways Genetic Testing and Molecular Biomarkers (IF1.795), Pub Date : 2021-03-17, DOI: 10.1089/gtmb.2020.0166 Shika Hanif Malgundkar, Ikram Burney, Mansour Al Moundhri, Moza Al Kalbani, Ritu Lakhtakia, Aikou Okamoto, Yahya Tamimi
Background:E2F5 is a transcription factor that is overexpressed in the early stages of ovarian cancer and has been suggested as a potential biomarker for early detection. In this study, we aimed to examine the role of E2F5 in invasion and proliferation of ovarian cancer cells.